The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Glucosamine Pharma Nord 400 mg Capsules

Pharma Nord ApSPA1242/001/001

Main Information

Trade NameGlucosamine Pharma Nord 400 mg Capsules
Active SubstancesGlucosamine
Dosage FormCapsule, hard
Licence HolderPharma Nord ApS
Licence NumberPA1242/001/001

Group Information

ATC CodeM01AX Other antiinflammatory and antirheumatic agents, non-steroids
M01AX05 glucosamine


License statusAuthorised
Licence Issued28/10/2005
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back